State Of Wisconsin Investment Board Uni Qure N.V. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $4,187 - $7,381	-624 Reduced 1.69%	36,261 $243,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $21,917 - $43,756	-1,971 Reduced 5.07%	36,885 $422,000
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $22,196 - $27,384	-1,187 Reduced 2.96%	38,856 $782,000
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $45,988 - $69,338	-2,538 Reduced 5.96%	40,043 $907,000
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $65,339 - $98,277	3,848 Added 9.93%	42,581 $799,000
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $131,933 - $205,174	10,033 Added 34.96%	38,733 $722,000
Q1 2022 May 13, 2022	BUY	$14.54 - $21.5 $417,298 - $617,050	28,700 New	28,700 $519,000

155

40.8M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $740M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.